Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Progenics Pharmaceuticals Inc (NASDAQ:PGNX)

6.81
Delayed Data
As of Sep 03
 -0.48 / -6.58%
Today’s Change
4.26
Today|||52-Week Range
11.15
-9.92%
Year-to-Date
No recent news for Progenics Pharmaceuticals Inc.

Today’s Trading

Previous close7.29
Today’s open7.37
Day’s range6.80 - 7.46
Volume999,242
Average volume (3 months)1,536,130
Market cap$508.0M
Dividend yield--
Data as of 3:59pm ET, 09/03/2015

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)-1,037.50%
Earnings growth (next 5 years)+7.00%
Revenue growth (last year)+464.45%
P/E ratio166.8
Price/Sales11.63
Price/Book4.06

Competitors

 Today’s
change
Today’s
% change
OMEROmeros Corp-0.87-6.46%
SRNESorrento Therapeutic...-0.61-4.58%
TBPHTheravance Biopharma...-0.95-6.42%
VNDAVanda Pharmaceutical...-0.25-2.05%
Data as of 3:59pm ET, 09/03/2015

Financials

Next reporting dateNovember 9, 2015
EPS forecast (this quarter)-$0.13
Annual revenue (last year)$44.4M
Annual profit (last year)$4.4M
Net profit margin9.94%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Mark Robert Baker
CFO, Treasurer, Principal Accounting Officer &
VP
Angelo William Lovallo
Corporate headquarters
Tarrytown, New York

Forecasts

Partner Offers